Corcept Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CORT and other ETFs, options, and stocks.About CORT
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.
CEOJoseph K. Belanoff
CEOJoseph K. Belanoff
Employees500
Employees500
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded1998
Founded1998
Employees500
Employees500
CORT Key Statistics
Market cap7.74B
Market cap7.74B
Price-Earnings ratio64.31
Price-Earnings ratio64.31
Dividend yield—
Dividend yield—
Average volume752.29K
Average volume752.29K
High today$74.22
High today$74.22
Low today$72.47
Low today$72.47
Open price$72.97
Open price$72.97
Volume686.74K
Volume686.74K
52 Week high$117.33
52 Week high$117.33
52 Week low$46.38
52 Week low$46.38
CORT News
Simply Wall St 23h
The Bull Case For Corcept Therapeutics Could Change Following Positive ROSELLA Phase 3 Ovarian Cancer DataCorcept Therapeutics recently announced new late-breaking data from its pivotal Phase 3 ROSELLA trial at the ESMO 2025 Annual Meeting, revealing that relacorila...
People also own
Based on the portfolios of people who own CORT. This list is generated using Robinhood data, and it’s not a recommendation.